CompletedNot Applicable

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

China64 participantsStarted 2017-07-31

Plain-language summary

The aim of the study was to evaluate the efficacy, safety, and cognitive function of transcranial direct current stimulation (tDCS) in chronic schizophrenia patients with tardive dyskinesia (TD).

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Right-handed;
✓. meeting the diagnosis of schizophrania;
✓. had been receiving antipsychotic drugs for at least 12 months;
✓. at least one AIMS item rated(moderate) or at least two AIMS items rated ≥2(mild);
✓. All patients volunteered to participate in this study.

Exclusion criteria

✕. organic disorder that could cause movement disorders, mental retardation,and a history of substance dependence(except nicotine);
✕. with serious physical illness(e.g.severe cardiovascular diseases);
✕. with color blindness/weakness, stuttering, deafness.

What they're measuring

Abnormal Involuntary Movements Scale

Timeframe: Change from baseline AIMS(items1-7) total scores at 3 weeks and 5 weeks and 7 weeks

Trial details

NCT IDNCT03497013

SponsorSuzhou Psychiatric Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-08-11

View on ClinicalTrials.gov More Tardive Dyskinesia trials